Effects of Anthocyans on Cardiovascular and Sympathetic Function
NCT ID: NCT00634387
Last Updated: 2011-07-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2008-03-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Ascorbic Acid Reduce Sympathoexcitation in CHF?
NCT00550121
Transplanted-like Heart in Critical Ill Patients
NCT01930669
Effects of Cardiac Sympathetic Blockade in Patients With Chronic Heart Failure
NCT02282618
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
NCT06263452
Does Statin Therapy Reduce Sympathoexcitation in Hypertension?
NCT00497016
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Anthocyans
Anthocyans
Anthocyans
Anthocyans
B
no effective agent
Anthocyans
Anthocyans
placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anthocyans
Anthocyans
placebo
Anthocyans
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males
* Hypertension
35 Years
50 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MedPalett
UNKNOWN
Ullevaal University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ullevaal University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiovascular and Renal Research Center, Ulleval University Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AC2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.